News
Recent news about Panacea Capital and select portfolio companies
January 15, 2026
Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 15, 2026
Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
December 10, 2025
Chime Biologics Announces Strategic Collaboration with Beijing Libang Pharmaceutical on Global Blinatumomab Biosimilar Program
December 10, 2025